An official website of the United States government
September 29, 2026 Edition
News
Antiviral drug did not improve Long COVID symptoms
A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
News
tRNA treatment may help restore cystic fibrosis proteins
Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
News
Bacterial infection may alter developing gut
C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.
Displaying 288 - 294 of 912
Ancestry and descendants of African Americans buried at Catoctin Furnace
DNA analysis of people buried in an early African American cemetery revealed their ancestry and descendants in the United States.
Cell atlases give detailed views of human organs
Detailed cellular maps reveal the spatial organization of cells within the human kidney, intestine, and placenta.
Genetic variant associated with absence of COVID-19 symptoms
A genetic variant found in people with asymptomatic SARS-CoV-2 might lead to better ways to protect against COVID-19.
Hearing aids slow cognitive decline in people at high risk
Hearing aids cut the rate of cognitive decline by nearly half in older adults at high risk of dementia.
Research in Context
Progress toward universal vaccines
Recent pandemics have highlighted the need to be prepared for the next emerging disease, whenever it arrives. Researchers are now working to develop universal vaccines against diseases with pandemic potential.
Y chromosome affects cancer growth
Two studies found factors on the Y chromosome that lead to aggressive tumor growth, helping explain why some cancers have different prognoses in men and women.
How football raises the risk for chronic traumatic encephalopathy
The force of blows to the head that football players experienced over their lives better predicted chronic traumatic encephalopathy than the number of concussions.